"Addiction Medicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A medical specialty focused on the diagnosis and treatment of ADDICTIVE BEHAVIOR disorders, including SUBSTANCE-RELATED DISORDERS and IMPULSE CONTROL DISORDERS; and the management of co-occurring medical and psychiatric conditions
| Descriptor ID |
D000073316
|
| MeSH Number(s) |
H02.403.007
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Addiction Medicine".
Below are MeSH descriptors whose meaning is more specific than "Addiction Medicine".
This graph shows the total number of publications written about "Addiction Medicine" by people in this website by year, and whether "Addiction Medicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Addiction Medicine" by people in Profiles.
-
Addiction medicine in the time of COVID-19: An overview of the 2020 Joint Scientific Annual Conference of the International Society of Addiction Medicine and Canadian Society of Addiction Medicine. Subst Abus. 2021; 42(3):261-263.
-
Conduct and evaluation of final-year medical student summative assessments in Psychiatry and Addiction Medicine during COVID-19: an Australian University Medical School experience. Australas Psychiatry. 2021 12; 29(6):695-698.
-
Addiction Medicine After COVID-19: The Imperative of a Trained Workforce. Am J Prev Med. 2021 05; 60(5):729-731.
-
Addressing a rapidly changing service landscape during the COVID-19 pandemic: Creation of the Oregon substance use disorder resource collaborative. J Subst Abuse Treat. 2021 05; 124:108244.
-
COVID-19: Broadening the horizons of U.S. harm reduction practices through managed alcohol programs. J Subst Abuse Treat. 2021 05; 124:108225.
-
Flattening the curve of COVID-19 for medical education in psychiatry and addiction medicine. Australas Psychiatry. 2021 02; 29(1):31-34.
-
Addiction psychiatry and COVID-19: impact on patients and service provision. Ir J Psychol Med. 2020 Sep; 37(3):164-168.
-
President's message: the impact of the COVID-19 public health emergency on the practice of addiction medicine. J Addict Dis. 2020 Apr-Jun; 38(2):235-236.
-
A smartphone based e-Consult in addiction medicine: An initiative in COVID lockdown. Asian J Psychiatr. 2020 Jun; 51:102120.
-
A new graduate medical school curriculum in Psychiatry and Addiction Medicine: reflections on a decade of development. Australas Psychiatry. 2018 Aug; 26(4):422-428.